Preclinical studies demonstrate that probiotics have potential to restore GI eubiosis (a balanced, healthy gut microbiota) and dampen microglial-mediated neuroinflammation, improving motor outcomes and reduced α-synuclein aggregation, a hallmark of PD. The gene discussed is SNCA; the disease is Parkinson disease.